Page last updated: 2024-09-05

scymnol and ticlopidine

scymnol has been researched along with ticlopidine in 1 studies

Compound Research Comparison

Studies
(scymnol)
Trials
(scymnol)
Recent Studies (post-2010)
(scymnol)
Studies
(ticlopidine)
Trials
(ticlopidine)
Recent Studies (post-2010) (ticlopidine)
140410,2891,8934,671

Protein Interaction Comparison

ProteinTaxonomyscymnol (IC50)ticlopidine (IC50)
Alpha-2A adrenergic receptorHomo sapiens (human)0.382
Cytochrome P450 2D6Homo sapiens (human)6.2928
Alpha-2B adrenergic receptorHomo sapiens (human)0.304
Alpha-2C adrenergic receptorHomo sapiens (human)1.175
Cytochrome P450 2B6Homo sapiens (human)0.405
Cytochrome P450 2C19Homo sapiens (human)0.6678
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.426

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishida, H; Nakayasu, H; Nukaya, H; Tsuji, K1

Other Studies

1 other study(ies) available for scymnol and ticlopidine

ArticleYear
Study of the pharmacological effect of the bile salt, sodium scymnol sulfate, from Rhizoprionodon acutus. III. Protective effect of scymnol against vascular endothelial cell damage in a rat peripheral arterial occlusion model.
    Biological & pharmaceutical bulletin, 1999, Volume: 22, Issue:8

    Topics: Alanine Transaminase; Animals; Antithrombin III; Arginine; Arterial Occlusive Diseases; Aspartate Aminotransferases; Bile Acids and Salts; Cells, Cultured; Cholestanols; Elasmobranchii; Endothelium, Vascular; L-Lactate Dehydrogenase; Male; Peripheral Vascular Diseases; Pipecolic Acids; Rats; Rats, Wistar; Sulfonamides; Ticlopidine

1999